《即日市評》恆指「七連跌」守兩萬五 李寧逆市揚
受友邦(01299.HK)及阿裏巴巴(09988.HK)跌勢拖累,港股今日持續向下。市場觀望美聯儲會議,美企季績理想推動投資情緒,美股三大指數昨續創收市新高,道指及納指各升0.4%及0.3%;執筆之時美國十年期國債孳息率跌至1.524釐,美匯指數升至94.04,美股道指期貨最新跌11點或0.03%,納指期貨最新升0.04%。中國10月財新服務業PMI升至53.8(市場原預期53.1),內地疫情反覆,內地昨新增新冠本土病例佔93例,上證綜指全日跌7點或0.2%收3,498點、深證成指下滑0.07%,內地創業板指數跌0.4%,滬深兩市成交額共1萬億人民幣。
恆指低開38點,早段曾倒升87點見25,187點,其後再度向下,曾跌291點一度低見24,808點,全日跌74點或0.3%,收25,024點,連跌七日(累跌1,107點或4.2%);國指今日跌6點或0.08%,收8,856點;恆生科技指數跌40點或0.65%,報6,273點。大市全日成交總額1,199.49億元,滬港通南下交易淨流出3.92億元人民幣,深港通南下交易淨流入11.48億元人民幣。光伏股捱沽,保利協鑫(03800.HK)股價急滑14.7%,信義光能(00968.HK)股價走低7.3%。
【光伏股有沽壓 李寧逆市彈高】
友邦全日股價下滑2.4%收86.05元。野村發表報告,將友邦2021財年的新業務價值下調3.6%,新業務價值按年增長由上半年24%,放緩至第三季約9%,主要由於Delta變種病毒影響公司主要業務市場包括中國及東盟國家,而香港及印度疫情於第三季改善,加上基數較低,估計新業務價值增長達雙位數。該行預期,在第二波Delta變種病毒的打擊下,公司第三季中國市場新業務價值增長放緩,甚至可能出現負數,料全年則增長17%。
內地體育用品股逆市上揚,安踏(02020.HK)股價漲2.9%,李寧(02331.HK)股價反彈6.7%爲升幅最大藍籌股。高盛發表報告表示,昨與李寧管理層進行會議,公司指短期營運狀況良好及處於指引上限水平,管理層對明年銷售收入增長維持樂觀,指原材料價格面臨持續上升的風險,但指仍有空間通過產品組合和強勁的品牌勢頭,以緩解利潤率壓力。
【沽空比率上升 平安好醫生弱】
港股今日市寬續弱,主板股票的升跌比率爲18比23(上日爲15比26);恆指成份股今日17只股份上升,下跌股份38只,升跌比率爲28比63(上日爲35比62);大市今日錄沽空183.63億元,佔可沽空股份成交977.23億元的18.791%(上日15.812%)。
互聯網醫療股弱,阿裏健康(00241.HK)跌2.7%,平安好醫生(01833.HK)股價挫6.4%收30.75元。美銀證券發表研究報告,認爲平安好醫生的業務變化將爲近期的增長帶來壓力,預計每個會員的平均收入短期內下跌,料將在正常化基礎和增值服務交叉銷售下逐步恢復,因此將其評級由「買入」降至「中性」,公司2021及2022財年收入增長預測分別下調至75億及83億元人民幣,意味着按年分別增長9%及11%,目標價由77元削至39元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.